ScienceDex / Researcher record
Wiley, Henry
- National Eye Institute (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2012 | $107,144 | 2 | #37,326 |
| 2013 | $130,015 | 2 | #35,462 |
| 2014 | $237,604 | 4 | #29,240 |
| 2015 | $206,851 | 3 | #30,769 |
| 2016 | $223,036 | 4 | #30,373 |
| 2017 | $170,646 | 3 | #33,633 |
| 2018 | $176,854 | 3 | #34,908 |
| 2019 | $179,011 | 4 | #36,391 |
| 2021 | $310,273 | 4 | #32,432 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20122 records
- FY20132 records
- FY20144 records
- FY20153 records
- FY20164 records
- FY20173 records
- FY20183 records
- FY20194 records
- FY2021 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Wiley, Henry as a PI. Multi-PI records show the full award amount for context.
- 1ZIAEY000536-08ZIAContact PIPhase 2 Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) (14-EI-0078, 17-EI-0136)$93.1Kaward amount
- 1ZIAEY000572-02ZIAContact PIA Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis$93.1Kaward amount
- 1ZIAEY000566-03ZIAContact PIA Phase 3 Multicenter, Randomized, Sham-Controlled Study to Determine the Safety and Efficacy of Renexus in Macular Telangiectasia Type 2$77.6Kaward amount
- 1ZIAEY000555-06ZIAContact PIA Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab (16-EI-0159)$46.5Kaward amount
Award organization
Organizations that administered FY2021 awards listing Wiley, Henry as a PI.
FY2021 award administered by National Eye Institute ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardNational Eye Institute
- 2015$500K Cumulative Funding
- 2017$1M Cumulative Funding